4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory
Wopanga Zinthu, Kuyera Kwambiri, Kupanga Zamalonda
Dzina la mankhwala: 4-Aminopyridine
CAS: 504-24-5
Dzina la Chemical | 4-Aminopyridine |
Mawu ofanana ndi mawu | 4-AP;4-Pyridinamine;Fampridine;Dalfampridine;p-aminopyridine;γ-Aminopyridine |
Nambala ya CAS | 504-24-5 |
Nambala ya CAT | RF-PI539 |
Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
Molecular Formula | C5H6N2 |
Kulemera kwa Maselo | 94.12 |
Kusungunuka | Zosungunuka m'madzi, Ethanol |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera Kapena Wachikasu Wamakristalo |
Njira Yoyesera / Kusanthula | ≥99.5% (HPLC) |
Melting Point | 157.0 ~ 162.0 ℃ |
Madzi (KF) | ≤0.50% |
Phulusa la Sulfate | ≤0.20% |
2 - Aminopyridine | ≤0.10% |
3 - Aminopyridine | ≤0.10% |
Zonse Zonyansa | ≤0.50% |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Pharmaceutical Intermediates;API |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi zofunika kasitomala.
Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
4-Aminopyridine (CAS: 504-24-5) ndi imodzi mwa atatu a isomeric amines a pyridine, ndi yoyera kwambiri, yopangidwa ndi biologically yogwira ntchito, yomwe imagwiritsidwa ntchito kwambiri mu organic synthesis, synthesis of pharmaceutical intermediates ndi Active Pharmaceutical Ingredient (API). ) kaphatikizidwe.4-Aminopyridine (4-AP, Fampridine, Dalfampridine) imagwiritsidwa ntchito ngati chida chofufuzira pozindikiritsa subtypes za njira ya potaziyamu.Amagwiritsidwanso ntchito ngati mankhwala, kuti athetse zizindikiro zina za multiple sclerosis, ndipo amasonyezedwa kuti azitha kuyenda bwino mwa anthu akuluakulu omwe ali ndi mitundu yosiyanasiyana ya matendawa.Bungwe la US Food and Drug Administration (FDA) linavomereza chigawochi pa January 22, 2010. Fampridine imagulitsidwanso ku United States ndi Acorda Therapeutics komanso ngati Fampyra ku European Union, Canada, ndi Australia.